40
BioGene Therapeutics Inc. raises $3M under Reg D
Company raise · Closed · Offering $3M · Sold $3M · AUSTIN, TX · filed 2026-08-07
25
BioGene Therapeutics Inc. raises $250K under Reg D
Company raise · Closed · AUSTIN, TX · Form D filed 2026-08-06
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| DAVID TYRONNE HOWTON | Director |
| STEVE GLOVER | Director |
| STEPHEN VAN DEVENTER | Executive Officer, Director |
| DEEPAK SAMPATH | Director |
| RAJ PRUTHI | Director |
| PATROSKI LAWSON | Director |
Signed by Stephen Van Deventer, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
25
BioGene Therapeutics Inc. raises $250K under Reg D
Company raise · Closed · Offering $250K · Sold $250K · AUSTIN, TX · filed 2026-08-06
40
BioGene Therapeutics Inc. raises $3M under Reg D
Company raise · Closed · Offering $3M · Sold $3M · AUSTIN, TX · filed 2026-08-06
45
BioGene Therapeutics Inc. raises $4.5M under Reg D
Company raise · Closed · Offering $4.5M · Sold $4.5M · AUSTIN, TX · filed 2026-07-23